Developing a dissolvable, mucoadhesive vaginal film delivering standardized plant-derived antibiofilm compounds to eradicate BV pathogens while preserving beneficial Lactobacillus—a microbiome-friendly alternative to antibiotics.
Seeking Strategic Partners & Advisors
Current treatments fail to address the root cause, leading to recurrence rates above 50%
Traditional treatments contribute to growing antibiotic resistance, a global health crisis.
Over 50% of women experience BV recurrence within 12 months of antibiotic treatment.
Pathogenic bacteria form protective biofilms that resist conventional antibiotics.
We're developing a mucoadhesive vaginal film that delivers standardized plant-derived compounds to disrupt biofilms while preserving beneficial Lactobacillus species.
Mucoadhesive matrix designed for extended vaginal residence time and controlled release.
Standardized botanical antibiofilm agents targeting pathogenic bacteria selectively.
Designed to eradicate pathogens while promoting beneficial Lactobacillus growth.
*Research phase development targets
From application to action—see the complete mechanism of antibiofilm delivery
Discreet finger insertion—no applicator needed
Film adheres and dissolves, releasing compounds
Plant-derived agents target pathogenic matrix
Lactobacillus thrives as balance returns
Mucoadhesive polymers ensure precise application
Standardized botanical antibiofilm agents
Sustained therapeutic coverage
Microbiome-sparing formulation
Combining pharmaceutical precision with botanical science
Developing pH-responsive mucoadhesive polymers to maximize epithelial contact and drug residence time.
Researching standardized botanical extracts that work synergistically to disrupt biofilms and restore healthy vaginal flora.
Avoiding antibiotic resistance concerns while targeting BV effectively.
Designed to disrupt pathogenic biofilms while promoting beneficial flora.
Mucoadhesive delivery system for sustained therapeutic levels.
Natural compounds offering safety and efficacy without synthetic risks.
Developing evidence-based formulations with rigorous scientific validation.
Preserving beneficial bacteria while eradicating pathogens.
Reaching 10,000 women in 10 rural districts with affordable, effective BV treatment
Help us reach 10,000 women with affordable, effective treatment
We're seeking partners, advisors, and investors to help bring this innovative treatment to market. Contact us to learn more about collaboration opportunities.